Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction

Area of Science:

• Cardiology
• Molecular Biology
• Biomarker Discovery

Background:

• Left ventricular remodeling post-acute myocardial infarction (AMI) is a significant predictor of adverse outcomes.
• Circulating microRNAs (miRNAs) are emerging as potential biomarkers for cardiac pathologies, including heart failure progression.
• Identifying reliable biomarkers for early detection of remodeling is crucial for patient management.

Purpose of the Study:

• To investigate the association between plasma levels of specific miRNAs and left ventricular remodeling after AMI.
• To evaluate the predictive value of these miRNAs for mortality and heart failure development within six months post-AMI.

Main Methods:

• Prospective study involving 359 consecutive patients admitted with AMI.
• Plasma samples collected on admission; echocardiography performed at admission and six-month follow-up.
• Left ventricular remodeling defined as ≥10% increase in left ventricular end-diastolic volume.
• Plasma miRNA levels (miR-208b, miR-34a) analyzed for association with clinical outcomes.

Main Results:

• Plasma miR-208b and miR-34a levels were significantly elevated in patients with left ventricular remodeling.
• Increased miR-208b and miR-34a levels were strongly associated with a higher risk of 6-month mortality or heart failure.
• A combination panel of these two miRNAs demonstrated significant reclassification of patient risk.

Conclusions:

• Circulating miR-208b and miR-34a are potential biomarkers for predicting left ventricular remodeling following AMI.
• Elevated levels of these miRNAs indicate an increased risk of adverse outcomes, including mortality and heart failure.
• These miRNAs may aid in risk stratification and early identification of patients requiring closer monitoring.